Comprehensive support across the clinical development lifecycle — from first protocol to final study report.
We help define the right research question and build a protocol to answer it — including endpoint selection, study feasibility, sample size planning, and regulatory strategy appropriate to your therapeutic area and development phase.
We identify and qualify research sites, manage site activation, train study teams, and provide ongoing monitoring to keep studies compliant and enrolling to plan.
We design ethical, plain-language recruitment and retention strategies that respect participants' time and help studies reach their enrollment goals.
Electronic data capture, database design, data cleaning, and statistical analysis — delivered with the documentation and traceability regulators expect.
Support with regulatory submissions, ethics committee and institutional review board liaison, and the documentation needed to keep a study in good standing.
Adverse event collection and reporting, safety signal monitoring, and oversight structures that keep participant safety central throughout a trial.
Standard operating procedures, audits, and quality systems built around ICH Good Clinical Practice (GCP) and applicable regulations.
Clear, regulator-ready clinical study reports and support for transparent results disclosure.
We adapt our services to the stage of development, from first-in-human studies through post-marketing surveillance.
Early safety and dosing studies in small, closely monitored groups.
Studies assessing efficacy and side effects in a larger participant group.
Large, comparative studies to confirm effectiveness and monitor safety.
Post-marketing studies that track long-term safety and real-world use.
Reach out to discuss how our services can support your clinical development program.
Contact our team